Varian to purchase GE's radiotherapy unit
Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global
Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global installed base of 400 linear accelerator systems and some 340 treatment planning products, according to the companies. The sale does not include GE's radiotherapy manufacturing and engineering unit located in Buc, France, which is under review, according to GEMS.
The purchase, for an undisclosed amount of cash, is expected to be completed by the end of 1997. About 160 GEMS radiotherapy service professionals, technical support personnel, and support staff will join Varian on completion of the transaction. Varian executives said that the acquisition significantly broadens the Palo Alto, CA-based company's international radiotherapy support. For GEMS, the deal allows the vendor to focus more closely on its core medical imaging, services, and information technology businesses, according to Jeffrey Immelt, president and CEO.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
